Home > Insider Trading > Filing (0001562180-22-002139)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1531048	Inari Medical Inc.	NARI	Surgical & Medical Instruments & Apparatus (3841)	452902923

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1806426	Thomas Tu	C/O Inari Medical, Inc. 6001 Oak Canyon, Suite 100 Irvine CA 92618	Chief Medical Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-02-28	3,998	$0.46	82,272	No	4	M	Direct
Common Stock	Disposition	2022-02-28	1,998	$90.03	80,274	No	4	S	Direct
Common Stock	Disposition	2022-02-28	2,000	$90.00	78,274	No	4	S	Direct
Common Stock	Acquisiton	2022-03-01	2	$0.46	78,276	No	4	M	Direct
Common Stock	Disposition	2022-03-01	2	$90.00	78,274	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2022-02-28	3,998	$0.46	3,998	$0.46
Common Stock	Stock Option	Disposition	2022-03-01	2	$0.05	2	$0.46

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
201,586		2029-04-23	No	4	M	Direct
201,584		2029-04-23	No	4	M	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2021.
This transaction was executed in multiple trades at prices ranging from $90.00. to $90.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Option vested with respected with 25% of the underline shares on April 30, 2020 and vest with respect to the remaining shares in 36 equal monthly installment there after.